| 英文名称 | Ginsenoside Rk1 |
|---|---|
| 中文名称 | 人参皂苷Rk1 |
| CAS号 | 494753-69-4 |
| 分子式 | C42H70O12 |
| 分子量 | 767.00 |
| 外观 | |
| 沸点 | 854.5±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
| 英文名称 | Ginsenoside Rk1 |
|---|---|
| 中文名称 | 人参皂苷Rk1 |
| CAS号 | 494753-69-4 |
| 分子式 | C42H70O12 |
| 分子量 | 767.00 |
| 外观 | |
| 沸点 | 854.5±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000997
中文名称：人参皂苷Rk1
英文名称：Ginsenoside Rk1
英文别名：(3β,12β)-12-Hydroxydammara-20,24-dien-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside;3β,12β-Dihydroxydammar-20(21),24-diene-3-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside;Ginsenoside Rk1;PAN 30;
分子式：C42H70O12
分子量：767.00
CAS号：494753-69-4
纯度：HPLC≥98%
沸点：854.5±65.0 °C | Condition: Press: 760 Torr
密度：1.27±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数：12.85±0.70 | Condition: Most Acidic Temp: 25 °C
储存条件：-20℃，干燥、避光、密封
规格：5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位：四川省维克奇生物科技有限公司
供应电话：028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，化学合成，抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等，敬请关注！ 新批次有现货，欢迎咨询。
| Steamed Panax notoginseng attenuates renal anemia in an adenine-induced mouse model of chronic kidney disease | ||
| 来源：SCI：JOURNAL OF ETHNOPHARMACOLOGY | 作者：Min Gao | 备注：4.36 |
| 引用描述 | ||
The reference standards of notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rc, 20(S)–Rh1, 20(R)-Rh1, Rd, Rg6, F4, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, all with a purity ≥98%, were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). EPO was purchased from Chengdu Di'ao Jiuhong Pharmaceutical Factory (Chengdu, Sichuan, China). FEJ was purchased from Shandong Dong'e E'jiao Co., Ltd. | ||
| An integrated strategy of MS-network-based offline 2DLC-QTOF-MS/MS coupled with UHPLC-QTRAP®-MS/MS for the characterization and quantification of the non-polysaccharides in Sijunzi decoction | ||
| 来源：SCI：ANALYTICAL AND BIOANALYTICAL CHEMISTRY | 作者：Dong, Bangjian | 备注：影响因子：4.157 |
| 引用描述 | ||
Liquiritin apioside, liquiritin, neoliquiritin, isoliquiritin apioside, isoliquiritin, ononin, naringin, liquiritigenin, poricoic acid A, poricoic acid B, poricoic acid C, glycyrrhetinic acid, dehydropachymic acid, pachymic acid, ginsenoside Re, ginsenoside Rg1, ginsenoside Rf, isoliquiritigenin, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rg5, 20(S)-ginsenoside Rh1, notoginsenoside R1, ginsenoside Ro, ginsenoside Rc, formononetin, ginsenoside Rb2, glycyrrhizic acid, ginsenoside Rd, ginsenoside Rk1, and atractylenolide III were purchased from Chengdu DeSiTe Biological Technology Co., Ltd. (Chengdu, China) or Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China). | ||
![人参皂苷Rh1/人参皂甙Rh1/S-人参皂苷Rh1/(S型)人参皂苷Rh1/20(S)-人参皂苷Rh1/(20S)-人参皂苷Rh1/(2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羟基-17-((S)-2-羟基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氢-1H-环戊[a]菲-6-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇](/image/145965)
![人参皂苷Rg2/20(S)-人参皂苷Rg2/人参皂甙Rg2/(S型)人参皂苷Rg2/人参皂苷Rg2-S型/(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羟基-17-((S)-2-羟基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氢-1H-环戊[a]菲-6-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-3-基)氧基)-6-甲基四氢-2H-吡喃-3,4,5-三醇/20S-人参皂苷Rg2](/image/145972)
![三七皂苷R1/人参皂苷R1/(2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-3,12-二羟基-4,4,8,10,14-五甲基十六氢-1H-环戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇/三七皂甙R1](/image/145982)
